NCT02702830View on ClinicalTrials.gov

MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Breast Cancer After Chemotherapy Treatment

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

August 25, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Healthy SubjectStage IA Breast CancerStage IB Breast CancerStage IIA Breast CancerStage IIB Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast Cancer
Interventions
OTHER

Cardiopulmonary Exercise Testing

Undergo CPET

DEVICE

Magnetic Resonance Imaging

Undergo MRI

Trial Locations (1)

27157

Comprehensive Cancer Center of Wake Forest University, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT02702830 - MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Breast Cancer After Chemotherapy Treatment | Biotech Hunter | Biotech Hunter